Bliss Gvs Pharma Limited was incorporated on December 11, 1984, as Public Limited Company. It is listed on Bombay and Delhi Stock Exchange. The companyâ€™s most unique product is â€˜Today Vaginal Contraceptiveâ€™, a safe female contraceptive aimed at furthering Planned Parenthood...
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bliss GVS Pharma Ltd. has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Bliss GVS Pharma Ltd. should be analysed on a Standalone basis
CAGR Colour Code Guide
Book Value per Share
Key Financial Parameter
Performance Ratio Colour Code Guide
Return on Equity (%)
Operating Profit Margin (%)
Net Profit Margin (%)
Debt to Equity
Working Capital Days
Cash Conversion Cycle
Promoter's Holding & Share Pledging
* Pledged shares as % of Promoter's holding (%)
1. Is Bliss GVS Pharma Ltd. a good quality company?
MoneyWorks4Me analysed the past 10-year performance of Bliss GVS Pharma Ltd. and arrived at the following conclusion:
Past 10 year's financial track record indicates that Bliss GVS Pharma Ltd. is a average quality company. However, for specific investment actions please connect with your investment advisor.
2. Is current market price of Bliss GVS Pharma Ltd. a good price to buy it?
The 5-year analysis of Bliss GVS Pharma Ltd.'s performance infers:
Bliss GVS Pharma Ltd. earnings have grown by 7.1%, whereas share price has depreciated -3% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.
3. What is Bliss GVS Pharma Ltd. share price return in the past 10 years ?
We analysed the performance of Bliss GVS Pharma Ltd. share prices over the last 10 years. Here is what we found out:
Bliss GVS Pharma Ltd. share price has depreciated 15.9% annually over the past ten years.
Bliss Gvs Pharma Limited was incorporated on December 11, 1984, as Public Limited Company. It is listed on Bombay and Delhi Stock Exchange. The companyâ€™s most unique product is â€˜Today Vaginal Contraceptiveâ€™, a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception. Bliss also manufactures to US specification vaginal pessaries of Clotrimazole & Povidone Iodine in addition to Anal Suppositories for
Bliss Gvs Pharma Limited was incorporated on December 11, 1984, as Public Limited Company. It is listed on Bombay and Delhi Stock Exchange. The companyâ€™s most unique product is â€˜Today Vaginal Contraceptiveâ€™, a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception. Bliss also manufactures to US specification vaginal pessaries of Clotrimazole & Povidone Iodine in addition to Anal Suppositories for treatment of piles.
The company also manufacture wide range of Pessary Formulations, Suppository Formulations, Calcium Preparation, Protein Powders, Iron Preparation, Antibiotics, Analgesic & Antipyretics, Respiratory, Anti-inflammatory, Dermatological Preparations, Anti-Diarrhoeal products.
It has a sophisticated automatic plant situated at Palghar (approx. 90 km from Mumbai) in an Industrial area which is well-developed with all Infra-structural facilities. This site is around 1.5 km away from Palghar Railway Station on the Western Railway and is well-connected by road and rail to most parts of the country, including Mumbai.
The plant aims to be as the most modern and one of its kind in the Indian sub-continent, to manufacture suppositories. Complete overhaul and annual maintenance has kept the plant in excellent condition and fully operational with minimum down time. Spares and consumables are maintained at proper levels to prevent unnecessary delays and the company has made efforts to employ a qualified Maintenance Engineer since production should not be hampered in any way.
The Prescription drugs of the company include Antimalarial- Alaxin, Gvither, P-Alaxin, Gsunate and Lonart
Today contraceptive, available in different types- Today Regular, Today Economy, Today Premium.Maitri Vaginal Lubricant Pessary- PEG-1500, PEG-1000, Fragrance.
2010 â€¢ Commissioning of new State-of-Art Manufacturing Facility for Suppositories and Pessaries at Palghar. â€¢ Entry into Middle East through Commissioning of Manufacturing Unit for Suppositories and Pessaries through Strategic Joint venture. â€¢ S N. Kamath, Promoter & Managing Director of the company has received a National Award -2009 from Government of India in recognition outstanding performance Entrepreneurship under Medium Enterprises.
2011 â€¢ EU-GMP approval for Suppositories and Pessaries manufacturing facility at Palghar. â€¢ Entry into Russia and other CIS markets
2012 â€¢ Strategic Acquisition of Semi Solid Manufacturing unit to strengthen presence in dermatological segment. â€¢ Expansion of product portfolio by setting-up manufacturing Unit for Dry Powder for Injection, Ampoules, Eye/ Ear/Nose Drops at Daman.
2013 â€¢ Expansion of Research and Development Centre and DSIR approval. â€¢ Launch of strategic marketing unit for front-end integration.